论文部分内容阅读
日前,国家食品药品监督管理总局发布《国家药品不良反应监测年度报告(2013年)》。2013年,国家药品不良反应监测网络共收到药品不良反应/事件报告131.7万余份,比2012年增长9.0%。其中,新的和严重的药品不良反应/事件报告29.1万份,占同期报告总数的22.1%。药品不良反应报告县级覆盖率达到93.8%,全国每百万人口平均报告数量达到983份。统计分析显示,2013年药品不良反应/事件报告仍以医疗机构为主,药品生产企业报告较2012年有所增长。从涉及药品情况看,国家基本药物安全状况平稳,抗感染药报告
Recently, the State Food and Drug Administration released the “National Annual Report on Adverse Drug Reaction Monitoring (2013)”. In 2013, the national ADR monitoring network received a total of more than 1.137 million reports of adverse drug reactions / incidents, an increase of 9.0% over 2012. Among them, there were 291,000 new and serious adverse drug reactions / incidents reported, accounting for 22.1% of the total number of concurrent reports. Adverse drug reaction reports at the county level coverage reached 93.8%, the national average per million population report reached 983. Statistical analysis showed that in 2013, ADR / incidents were still reported mainly by medical institutions, and the number of pharmaceutical manufacturing enterprises reported an increase over 2012. From the perspectives of drugs involved, the state has maintained a steady state of essential medicines and reported anti-infectives